Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MARCHEX INC Director's Dealing 2014

Aug 1, 2014

34316_dirs_2014-08-01_e2d0c624-97af-4c2a-8169-aafce39033bf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MARCHEX INC (MCHX)
CIK: 0001224133
Period of Report: 2014-07-30

Reporting Person: ARENDS MICHAEL A (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-07-30 Class B Common Stock M 21875 $4.89 Acquired 424136 Direct
2014-07-30 Class B Common Stock M 27357 $4.89 Acquired 451493 Direct
2014-07-30 Class B Common Stock M 13046 $4.41 Acquired 464539 Direct
2014-07-30 Class B Common Stock M 6864 $4.41 Acquired 471403 Direct
2014-07-30 Class B Common Stock S 69142 $11.2015 Disposed 402261 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-07-30 Non-Qualified Stock Option (Right to Buy) $4.89 M 21875 Disposed 2020-05-11 Class B Common Stock (21875) Direct
2014-07-30 Non-Qualified Stock Option (Right to Buy) $4.89 M 27357 Disposed 2020-05-11 Class B Common Stock (27357) Direct
2014-07-30 Non-Qualified Stock Option (Right to Buy) $4.41 M 13046 Disposed 2022-12-20 Class B Common Stock (13046) Direct
2014-07-30 Non-Qualified Stock Option (Right to Buy) $4.41 M 6864 Disposed 2022-12-20 Class B Common Stock (6864) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Class B Common Stock 18100 Indirect
Class B Common Stock 6500 Indirect
Class B Common Stock 10500 Indirect

Footnotes

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10(b)5-1 trading plan adopted by the reporting person in 2014 and which such Rule 10(b)5-1 trading plan shall terminate on the earlier of all shares having been sold thereunder or December 31, 2015.

F2: This transaction was executed in multiple trades at prices ranging from $11.20 to $11.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, Marchex or a stockholder of Marchex full information regarding the number of shares and prices at which the transaction was effected.

F3: Reporting person disclaims beneficial ownership.

F4: Immediate exercisability.

F5: Option grant effective December 20, 2012 (the "Option Grant Date"). 25% of the options will vest on the first annual anniversary of the Option Grant Date. Thereafter, 1/12 of the remaining will vest quarterly thereafter for the following three years.

F6: One hundred percent (100%) of all options not already vested as of the date hereof, shall become immediately vested upon the occurrence of both (a) a Change of Control (as defined in such reporting person's award agreements), (b) followed by (i) a termination without cause of such reporting person's employment by the Issuer or any successor thereto, (ii) a Diminution in Duties (as defined in such reporting person's award agreements) with respect to the reporting person, or (iii) the twelve month anniversary of the occurrence of the Change of Control.

F7: Option grant effective the Option Grant Date. The options have been issued in three separate tranches, representing approximately 32% ("Tranche A"), 33% ("Tranche B") and 35% ("Tranche C"), respectively, of such award. Such options shall vest on the later of (a) the twelve month anniversary of the Option Grant Date (Tranche A), the twenty-four month anniversary of the Option Grant Date (Tranche B) or the thirty month anniversary of the Option Grant Date (Tranche C), and (b) the last day of the first 20 consecutive trading day period after the Option Grant Date during which the average closing price of the Issuer's Class B Common Stock over such period is equal to or greater than $4.50 (Tranche A), $5.25 (Tranche B) or $6.00 (Tranche C).